secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001636422-22-000027
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst shareholders reject advisory vote on executive compensation at 2022 annual meeting
--------------------------------------------------------------------------------

- Say-on-pay proposal received 20,019,370 for, 23,100,748 against, 46,068 abstain, 3,010,476 broker non-votes.
- Both Class III director nominees elected: Duncan Gallagher (28,400,049 for, 14,766,137 withheld) and Mark B. Templeton (33,605,452 for, 9,560,734 withheld).
- Ratification of Ernst & Young as auditor for FY2022 passed: 45,758,062 for, 378,823 against, 39,777 abstain.
- Total shares present at meeting: 46,176,662 of 53,937,142 entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000027/0001636422-22-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000027/hcat-20220614.htm
  HTML page:      https://secwatch.observer/filing/0001636422-22-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer